تغییرات بیان mir-183 و ژن foxo1 در سلول‌های تک‌هسته‌ای خون محیطی بیماران مبتلا به سرطان پستان

زمینه و هدف: امروزه، سرطان به عنوان یک معضل عمده‌ی بهداشتی و تاثیرگذار بر سلامت جامعه محسوب می‌گردد. microrna ها گروهی از rna های حفاظت شده تک‌رشته‌ای کوتاه (بین 19 تا 23 نوکلئوتید) و غیر کد کننده هستند که به عنوان تنظیم‌کننده‌های بعد از رونویسی بیان ژن، در گستره وسیعی از حیوانات، گیاهان و ویروس‌ها، عمل می‌کنند. ژن foxo1 یکی از اهداف mir-183 می‌باشد که در بلوغ لنفوسیت‌ها موثر بوده و افزایش بیان mir-183 در بیماران مبتلا به سرطان باعث تداخل در عملکرد سیستم ایمنی خواهد شد. هدف از این تحقیق بررسی تغییرات بیان mir-183 و ژن foxo1 در سلول‌های تک‌هسته‌ای خون محیطی (pbmcs) مبتلایان به سرطان پستان بود.روش کار: مطالعه بر روی 60 نمونه شامل دو گروه بیمار و سالم انجام شد. مراحل انجام مطالعه شامل: جداسازی سلول‌های pbmc، استخراج rna از pbmcs به دست آمده از بیماران، طراحی پرایمرهای مخصوص برای ژن‌های هدف، سنتز cdna از rna های به دست آمده، کنترل کیفیت cdna سنتز شده با استفاده از ژن خانه‌دار بتا اکتین و 5srrna و حصول اطمینان از سلامت cdna، انجام real time pcr جهت بررسی تغییرات بیان ژن foxo1، بررسی تغییرات میزان mir-183 و در نهایت آنالیزهای آماری توسط نرم‌افزار rest 2009 انجام شد.یافته‌ها: با آنالیز داده‌ها مشخص گردید که افزایش معنی‌دار mir-183 (p <0.001) و کاهش foxo1 (p < 0.05) در خون بیماران مبتلا به سرطان پستان وجود دارد.نتیجه‌گیری: کاهش بیان ژن foxo1 و نیز افزایش بیان mir-183 باعث کاهش بلوغ لنفوسیت‌ها شده و این عملکرد باعث تضعیف و سرکوب سیستم ایمنی می‌گردد که نتیجه این اتفاق تکثیر و تمایز سلول‌های سرطانی و گسترش تومور می‌گردد که می‌توان از آن به عنوان بیومارکر تشخیصی یا پیش‌آگهی استفاده نمود.

mir-183 and foxo1 gene expression changes in peripheral blood mononuclear cells of breast cancer patients

background & aims: today، cancer is considered as a major health problem and affects the health of society. breast cancer is the second leading cause of cancer death in women after lung cancer. according to epidemiological studies، cancer is the second most common cause of death after cardiovascular disease worldwide and the third leading cause of death after cardiovascular disease and accidents in less developed countries. cancer occurs as a result of uncontrolled cell division، which is the result of environmental factors and genetic disorders. the four key genes involved in cancer cell development include oncogenes، tumor suppressor genes، dna repair genes، and programmed death genes. the prevalence of breast cancer varies from about 8 to 12 women in different communities. about 30% of all monogenic breast cancers are due to mutations in the brca breast cancer genes، which will eventually lead to breast cancer with a dominant inheritance pattern. repair genes naturally make proteins and enzymes that repair damaged genes. when these genes are mutated، they cannot repair the defects of other genes. one of the repairing genes is brca-1 gene، which has a hereditary role in the production and growth of cancer cells in female breasts when it has a mutation.micrornas are a group of short، single-stranded (between 19 and 23 nucleotides) and non-coding conserved rnas that act as post-transcriptional regulators of gene expression in a wide range of animals، plants، and viruses. the foxo1 gene is one of the targets of mir-183، which is involved in the maturation of lymphocytes، and increased expression of mir-183 in cancer patients will interfere with immune function. studies on mir-183-3p in breast cancer have shown that this microrna is a tumor suppressor-mir (ts-mir) that prevents tumor formation and differentiation and has an inhibitory role. another feature is the inhibition of cell proliferation and metastasis and stops the cell cycle in the g1 stage. mir-183 can play a role in other cancers in addition to breast cancer، depending on the type of target and location of activity. the aim of this study was to evaluate the expression changes of mir-183 in nuclear nuclei of breast cancer patients.methods: the study was performed on 60 samples including two groups of patients and healthy people. all actions and tests performed in this research and sampling have been approved by the work instructions of the ethics committee of qom branch of the azad university (ethics code: ir.iau.qom.rec.1397.010). study steps include: extraction of peripheral blood mononuclear cells (pbmcs)، extraction of rna from pbmcs obtained from patients، design of specific primers for target genes، synthesis of cdna from rnas obtained، quality control of cdna synthesized with use of beta-actin and 5srrna housekeeping genes and ensure cdna health، real time pcr to study changes in foxo1 gene expression، changes in mir-183 and finally statistical analysis. in this study، the results obtained from real-time pcr (ct) were analyzed using linreg software by examining the amount of fluorescence read by the device for each sample and the efficiency of each sample، the ct of the reference gene and the target gene in both patient and healthy groups the data were then used and analyzed by rest 2009 to determine whether the p-value was less than 0.05.results: the results of analysis of data obtained from real time-pcr show that the expression of foxo1 gene in peripheral blood cells significantly decreases in samples of breast cancer patients compared to healthy individuals (p < 0.05). while in the expression of mir-183 gene، a significant increase was observed in the samples of people with breast cancer compared to the group of healthy people (p <0.001).conclusion: decreased expression of foxo1 gene reduces the maturation of lymphocytes and this function weakens and suppresses the immune system، which results in the proliferation and differentiation of cancer cells and tumor spread، which can be used as a biomarker. limitations of the study include the small number of patients، the lack of classification of patients based on markers such as her2nue، brca-1 and other diagnostic markers.